Details of the Metabolic Reaction (MR)
| General Information of This Metabolic Reaction (MR) (ID: MR004667) | ||||||
|---|---|---|---|---|---|---|
| Formula |
![]() Oxidationn deamination; carboxylation
![]() |
|||||
| Reactant | Imatinib mesylate | Product | Deaminated imatinib | |||
| Reactant Info | Product Info | |||||
| Metabolic Type | Multi-steps Reaction - Oxidationn deamination; carboxylation | |||||
| Other MR(s) Related to The Product of This MR | |||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other MR(s) That Produce The Product of This MR | |||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||
| References | ||||||
|---|---|---|---|---|---|---|
| 1 | In vitro biotransformation of imatinib by the tumor expressed CYP1A1 and CYP1B1 | |||||
| 2 | Metabolism and disposition of imatinib mesylate in healthy volunteers | |||||
| 3 | Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. | |||||
| 4 | Participation of CYP2C8 and CYP3A4 in the N-demethylation of imatinib in human hepatic microsomes | |||||
| 5 | Dealkylation and N-oxidation in the metabolism of i-diethylcarbamyl-4-methylpiperazine in the rat | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.



